Antibiotic resistance among Helicobacter pylori clinical isolates in Lima, Peru

References

• KhalifaMMSharafRRAzizRKHelicobacter pylori: a poor man’s gut pathogen?Gut Pathog201021220356368
   PubMed Web of Science ®Google Scholar
• FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20153865E359E386
   Web of Science ®Google Scholar
• SariY-SCanDTunaliVSahinOKocOBenderOH pylori: Treatment for the patient only or the whole family?World J Gastroenterol20081481244124718300351
   PubMed Web of Science ®Google Scholar
• GrahamDYFischbachLHelicobacter pylori treatment in the era of increasing antibiotic resistanceGut20105981143115320525969
   PubMed Web of Science ®Google Scholar
• LeeYCChiangTHChouCKAssociation between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysisGastroenterology2016150511131124.e526836587
   PubMed Web of Science ®Google Scholar
• SotoGBautistaCTRothDEHelicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapyJ Infect Dis200318891263127514593583
   PubMed Web of Science ®Google Scholar
• Ramirez-RamosAGilmanRHLeon-BaruaRRapid recurrence of Helicobacter pylori infection in Peruvian patients after successful eradicationClin Infect Dis1997255102710319402351
   PubMed Web of Science ®Google Scholar
• JafriNSHornungCAHowdenCWMeta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatmentAnn Intern Med20081481292393118490667
   PubMed Web of Science ®Google Scholar
• GattaLVakilNLeandroGDi MarioFVairaDSequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and childrenAm J Gastroenterol20091041230693079 quiz 108019844205
   PubMed Web of Science ®Google Scholar
• EssaASKramerJRGrahamDYTreiberGMeta-analysis: four-drug, three-antibiotic, non-bismuth-containing “concomitant therapy” versus triple therapy for Helicobacter pylori eradicationHelicobacter200914210911819298338
   PubMed Web of Science ®Google Scholar
• GreenbergERAndersonGLMorganDR14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trialLancet2011378979050751421777974
   PubMed Web of Science ®Google Scholar
• MorganDRTorresTSextonRRisk of recurrent helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communitiesJAMA2013309657858623403682
   PubMed Web of Science ®Google Scholar
• de FrancescoVGiorgioFHassanCWorldwide H. pylori antibiotic resistance: a systematic reviewJ Gastrointest Liver Dis2010194409414
   PubMed Web of Science ®Google Scholar
• CamargoMCGarcíaARiquelmeAThe problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin AmericaAm J Gastroenterol2014109448549524589670
   PubMed Web of Science ®Google Scholar
• PilcoPPayetECáceresEGastric cancer in LimaRev Gastroenterol Peru2006264377385 Available from: http://europepmc.org/abstract/med/17211488Accessed September 25, 2015 Spanish17211488
   PubMedGoogle Scholar
• Mochizuki TamayoHNoriega AldaveAPAntimicrobial susceptibility of helicobacter pylori to levofloxacin determined in a miniwell format and disk diffusion tests using egg yolk agarRev Gastroenterol Peru2011313224229 Spanish22086316
   PubMedGoogle Scholar
• VasquezAValdezYGilmanRHMetronidazole and clarithromycin resistance in Helicobacter pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk agar in a miniwell formatAm Soc Microbiol199634512321234
   Google Scholar
• BergDEGilmanRHLelwala-GurugeJHelicobacter pylori populations in Peruvian patientsClin Infect Dis199725599610029402344
   PubMed Web of Science ®Google Scholar
• WongBC-YLamSKWongWMHelicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trialJAMA2004291218719414722144
   PubMed Web of Science ®Google Scholar
• CianciRMontaltoMPandolfiFGasbarriniGBCammarotaGThird-line rescue therapy for Helicobacter pylori infectionWorld J Gastroenterol200612152313231916688818
   PubMed Web of Science ®Google Scholar
• ValdiviesoMBussalleuASextonRClinical, epidemiologic, and genomic studies (SWOG S1119) of Helicobacter pylori in Lima, Peru: role of contaminated waterJ Cancerol2016325263
   Google Scholar
• BoehnkeKFEatonKAValdiviesoMBakerLHXiCAnimal model reveals potential waterborne transmission of Helicobacter pylori infectionHelicobacter201520532633325664781
   PubMed Web of Science ®Google Scholar
• YamaokaYKitaMKodamaTSawaiNKashimaKImanishiJInduction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strainsGut19974144424519391240
   PubMed Web of Science ®Google Scholar
• AthertonJCCoverTLTwellsRJMoralesMRHawkeyCJBlaserMJSimple and accurate PCR-based system for typing vacuolating cytotoxin alleles of Helicobacter pyloriJ Clin Microbiol19993792979298210449485
   PubMed Web of Science ®Google Scholar
• The European Committee on Antimicrobial Susceptibility TestingBreak-point tables for interpretation of MICs and zone diameters. Version 3.12013 Available from: http://www.eucast.orgAccessed October 4, 2016
   Google Scholar
• CamargoMCGarcíaARiquelmeAThe problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America20141094485495
   Google Scholar
• SuPLiYLiHAntibiotic resistance of Helicobacter pylori isolated in the Southeast Coastal Region of ChinaHelicobacter201318427427923418857
   PubMed Web of Science ®Google Scholar
• CaliskanRTokmanHBErzinYSaribasSYukselPMajor Article strains to five antibiotics, including levofloxacin, in Northwestern TurkeyRev Soc Bras Med Trop201548327828426108005
   PubMed Web of Science ®Google Scholar